Lactic Acid Induces Fibroblast Growth Factor 23 (FGF23) Production in UMR106 Osteoblast-like Cells

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2021 Nov 3

PMID 34731356

Citations 4

Authors

Jana Alber

Michael Foller

Affiliations

Soon will be listed here.

Abstract

Endocrine and paracrine fibroblast growth factor 23 (FGF23) is a protein predominantly produced by bone cells with strong impact on phosphate and vitamin D metabolism by targeting the kidney. Plasma FGF23 concentration early rises in kidney and cardiovascular diseases correlating with progression and outcome. Lactic acid is generated in anaerobic glycolysis. Lactic acidosis is the consequence of various physiological and pathological conditions and may be fatal. Since FGF23 production is stimulated by inflammation and lactic acid induces pro-inflammatory signaling, we investigated whether and how lactic acid influences FGF23. Experiments were performed in UMR106 osteoblast-like cells, Fgf23 mRNA levels estimated from quantitative real-time polymerase chain reaction, and FGF23 protein determined by enzyme-linked immunosorbent assay. Lactic acid dose-dependently induced Fgf23 gene expression and up-regulated FGF23 synthesis. Also, Na-lactate as well as formic acid and acetic acid up-regulated Fgf23. The lactic acid effect was significantly attenuated by nuclear factor kappa-light-chain enhancer of activated B-cells (NFκB) inhibitors wogonin and withaferin A. Lactic acid induces FGF23 production, an effect at least in part mediated by NFκB. Lactic acidosis may, therefore, be paralleled by a surge in plasma FGF23.

Citing Articles

Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells.

Munz S, Feger M, Foller M Sci Rep. 2023; 13(1):8420.

PMID: 37225713 PMC: 10209182. DOI: 10.1038/s41598-023-34858-6.

Tumor microenvironment-associated lactate metabolism regulates the prognosis and precise checkpoint immunotherapy outcomes of patients with lung adenocarcinoma.

Qiu S, Wang Y, Rao H, Que Q, Wu Y, Zhu R Eur J Med Res. 2022; 27(1):256.

PMID: 36411477 PMC: 9677690. DOI: 10.1186/s40001-022-00895-6.

Oral Acid Load Down-Regulates Fibroblast Growth Factor 23.

Vidal A, Pineda C, Raya A, Rios R, Espartero A, Munoz-Castaneda J Nutrients. 2022; 14(5).

PMID: 35268016 PMC: 8912769. DOI: 10.3390/nu14051041.

The regulation of FGF23 under physiological and pathophysiological conditions.

Rausch S, Foller M Pflugers Arch. 2022; 474(3):281-292.

PMID: 35084563 PMC: 8837506. DOI: 10.1007/s00424-022-02668-w.

References

Edmonston D, Wolf M . FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol. 2019; 16(1):7-19. DOI: 10.1038/s41581-019-0189-5. View

Bar L, Stournaras C, Lang F, Foller M . Regulation of fibroblast growth factor 23 (FGF23) in health and disease. FEBS Lett. 2019; 593(15):1879-1900. DOI: 10.1002/1873-3468.13494. View

Liu S, Tang W, Zhou J, Stubbs J, Luo Q, Pi M . Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006; 17(5):1305-15. DOI: 10.1681/ASN.2005111185. View

Mace M, Olgaard K, Lewin E . New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis. Int J Mol Sci. 2020; 21(22). PMC: 7699902. DOI: 10.3390/ijms21228810. View

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T . Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113(4):561-8. PMC: 338262. DOI: 10.1172/JCI19081. View

Avcioglu G, Ozbek Iptec B, Akcan G, Gorgun B, Fidan K, Carhan A . Effects of 1,25-Dihydroxy vitamin D on TNF-α induced inflammation in human chondrocytes and SW1353 cells: a possible role for toll-like receptors. Mol Cell Biochem. 2019; 464(1-2):131-142. DOI: 10.1007/s11010-019-03655-z. View

Vervloet M . Renal and extrarenal effects of fibroblast growth factor 23. Nat Rev Nephrol. 2018; 15(2):109-120. DOI: 10.1038/s41581-018-0087-2. View

Ben-Dov I, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-O M, Mohammadi M . The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007; 117(12):4003-8. PMC: 2066196. DOI: 10.1172/JCI32409. View

Goltzman D, Mannstadt M, Marcocci C . Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. Front Horm Res. 2018; 50:1-13. DOI: 10.1159/000486060. View

10.

Goetz R, Beenken A, Ibrahimi O, Kalinina J, Olsen S, Eliseenkova A . Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007; 27(9):3417-28. PMC: 1899957. DOI: 10.1128/MCB.02249-06. View

11.

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. DOI: 10.1038/36285. View

12.

Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt K . Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281(10):6120-3. PMC: 2637204. DOI: 10.1074/jbc.C500457200. View

13.

Liu H, Fergusson M, Castilho R, Liu J, Cao L, Chen J . Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007; 317(5839):803-6. DOI: 10.1126/science.1143578. View

14.

Chen T, Kuro-O M, Chen C, Sue Y, Chen Y, Wu H . The secreted Klotho protein restores phosphate retention and suppresses accelerated aging in Klotho mutant mice. Eur J Pharmacol. 2012; 698(1-3):67-73. DOI: 10.1016/j.ejphar.2012.09.032. View

15.

Mencke R, Olauson H, Hillebrands J . Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies. Adv Drug Deliv Rev. 2017; 121:85-100. DOI: 10.1016/j.addr.2017.07.009. View

16.

Chen Y, Huang C, Zhu S, Zou H, Xu C, Chen Y . Overexpression of HOTAIR attenuates Pi-induced vascular calcification by inhibiting Wnt/β-catenin through regulating miR-126/Klotho/SIRT1 axis. Mol Cell Biochem. 2021; 476(10):3551-3561. DOI: 10.1007/s11010-021-04164-8. View

17.

Kurosu H, Yamamoto M, Clark J, Pastor J, Nandi A, Gurnani P . Suppression of aging in mice by the hormone Klotho. Science. 2005; 309(5742):1829-33. PMC: 2536606. DOI: 10.1126/science.1112766. View

18.

Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S . Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 2016; 90(5):985-996. PMC: 5065745. DOI: 10.1016/j.kint.2016.05.019. View

19.

Grabner A, Amaral A, Schramm K, Singh S, Sloan A, Yanucil C . Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metab. 2015; 22(6):1020-32. PMC: 4670583. DOI: 10.1016/j.cmet.2015.09.002. View

20.

Bockmann I, Lischka J, Richter B, Deppe J, Rahn A, Fischer D . FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis. Int J Mol Sci. 2019; 20(18). PMC: 6770314. DOI: 10.3390/ijms20184634. View